Ithan D. Peltan

Ithan D. Peltan is an Adjunct Professor in the Department of Internal Medicine at the University of Utah. He is a board-certified specialist in Critical Care Medicine and Pulmonary Disease, with a clinical focus on acute respiratory distress syndrome (ARDS), sepsis, and healthcare for critically ill patients. His research spans clinical trials, vaccine effectiveness, and implementation science in critical care settings.

Dr. Peltan's work emphasizes outcomes in mechanically ventilated patients, sepsis management, and pandemic response strategies. He has contributed extensively to understanding SARS-CoV-2 vaccine efficacy, ARDS epidemiology, and sepsis-related delays in treatment. His research often involves multicenter collaborations and mixed-methods analyses.

Notable trends in his publications include studies on COVID-19 hospitalizations, diabetic ketoacidosis, and respiratory failure. He frequently collaborates with the IVY Network and PETAL Clinical Trials Network, focusing on vaccine effectiveness, sepsis protocols, and critical care quality improvement.

Dr. Peltan's academic training includes an MD from Harvard Medical School, an MS in Public Health from the University of Washington, and an internship at Massachusetts General Hospital. His work appears in journals like JAMA, Critical Care, and Annals of the American Thoracic Society.